GLP-1 Weight Loss Drugs Drive First Significant Decline in U.S. Obesity Rate
A new Gallup survey reveals the U.S. obesity rate is declining, directly linked to GLP-1 drug use (Ozempic, Zepbound). Understand the public health impact.
Zepbound
Content Daily News